SCHEMBL30104126

SCHEMBL30104126

CCOC(=O)C(=[N+]=[N-])c1ccccc1OC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.54
KMT2A Q03164 3/20 0.54
LMNA P02545 3/20 0.54
MEN1 O00255 2/20 0.54
PLIN1 O60240 1/20 0.54
POLB P06746 1/20 0.54
PLIN5 Q00G26 1/20 0.54
ABHD5 Q8WTS1 1/20 0.54
GAA P10253 2/20 0.48
CTSD P07339 1/20 0.46
CYP19A1 P11511 1/20 0.46
TSHR P16473 1/20 0.45
SMN1; SMN2 Q16637 3/20 0.44
HPGD P15428 3/20 0.44
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 1/20 0.44
PKM P14618 1/20 0.44
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
NPSR1 Q6W5P4 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27981110 0.84 CTSD (0.51) MAPTKMT2ALMNAPOLBGAA
SCHEMBL28319996 0.84 TSHR (0.50) MAPTKMT2ALMNAMEN1PLIN1
SCHEMBL18328499 0.84 LMNA (0.52) MAPTKMT2ALMNAMEN1PLIN1
SCHEMBL30104122 0.82 ALDH1A1 (0.49) MAPTKMT2ALMNAMEN1PLIN1
SCHEMBL22981059 0.81 TSHR (0.46) MAPTKMT2ALMNAMEN1GAA
SCHEMBL29524844 0.81 TSHR (0.46) MAPTKMT2ALMNAMEN1GAA
SCHEMBL4589656 0.80 KMT2A (0.60) MAPTKMT2ALMNAMEN1PLIN1
SCHEMBL30322741 0.80 KMT2A (0.60) MAPTKMT2ALMNAMEN1PLIN1
SCHEMBL18740870 0.80 STAT3 (0.50) MAPTKMT2ACTSDSMN1; SMN2HPGD
SCHEMBL30104115 0.79 HCRTR1 (0.54) MAPTKMT2ALMNAMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11518768-B2 Artificial metalloenzymes containing noble metal-porphyrins THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-12-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11518768-B2 Artificial metalloenzymes containing noble metal-porphyrins PPIH, HMBS, PPOX MAPT 3431/4885KMT2A 1549/4885LMNA 4278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.